{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:41:57Z","timestamp":1788493317166,"version":"build-2803163510"},"reference-count":29,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2021,3,23]]},"abstract":"<jats:p>Background: White matter hyperintensities (WMH) on MRI have been reported to increase the risk of conversion from mild cognitive impairment (MCI) to Alzheimer\u2019s disease (AD). However, effects of the progression of WMH on the cognition of patients with MCI remains unclear to date. Objective: To investigate the association between WMH progression and cognitive decline in amnestic MCI patients. Methods: Thirty-eight subjects with amnestic MCI were analyzed prospectively every year for 2 years. Fourteen MCI subjects dropped out on the final visit, and therefore 24 subjects with MCI were analyzed for the entire duration. The volumes of periventricular hyperintensities (PVH) and deep WMH (DWMH) were measured on T2 FLAIR using the 3D-slicer. The associations between PVH\/DWMH progression and cognitive decline were investigated. Results: An increase in DWMH volume significantly correlated with changes in Mini-Mental State Examination and category verbal fluency scores, whereas an increase in PVH volume did not correlate with changes in any item. Conclusion: DWMH progression was closely associated with a decline in frontal lobe function and semantic memory, suggesting that WMH progression might affect some AD pathophysiologies in amnestic MCI patients.<\/jats:p>","DOI":"10.3233\/jad-201451","type":"journal-article","created":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T22:37:53Z","timestamp":1613255873000},"page":"877-883","source":"Crossref","is-referenced-by-count":18,"title":["Association of White Matter Hyperintensity Progression with Cognitive Decline in Patients with Amnestic Mild Cognitive Impairment"],"prefix":"10.1177","volume":"80","author":[{"given":"Kentaro","family":"Hirao","sequence":"first","affiliation":[{"name":"Department of Geriatric Medicine, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Ultrahigh Field MRI, Institute for Biomedical Sciences, Iwate Medical University, Iwate, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akito","family":"Tsugawa","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rieko","family":"Haime","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raita","family":"Fukasawa","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Kanetaka","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Umahara","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruo","family":"Hanyu","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-201451_ref1","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1007\/s00415-008-0874-y","article-title":"Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia","volume":"255","author":"van Straaten","year":"2008","journal-title":"J Neurol"},{"key":"10.3233\/JAD-201451_ref2","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1001\/archneurol.2012.1527","article-title":"Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community","volume":"69","author":"Brickman","year":"2012","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-201451_ref3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neurobiolaging.2014.07.019","article-title":"Reconsidering harbingers of dementia: Progression of parietal lobe white matter hyperintensities predicts Alzheimer\u2019s disease incidence","volume":"36","author":"Brickman","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-201451_ref4","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.jalz.2015.05.014","article-title":"The effect of white matter hyperintensities on neurodegeneration in mild cognitive impairment","volume":"11","author":"Tosto","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-201451_ref5","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/ggi.13767","article-title":"Association of serum cystatin C with white matter abnormalities in patients with amnestic mild cognitive impairment","volume":"19","author":"Hirao","year":"2019","journal-title":"Geriatr Gerontol Int"},{"key":"10.3233\/JAD-201451_ref6","doi-asserted-by":"crossref","first-page":"e950","DOI":"10.1212\/WNL.0000000000008864","article-title":"White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease","volume":"94","author":"Soldan","year":"2020","journal-title":"Neurology"},{"key":"10.3233\/JAD-201451_ref7","first-page":"1238","article-title":"A diagnostic approach in Alzheimer\u2019s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET","volume":"36","author":"Minoshima","year":"1995","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-201451_ref8","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.neuroimage.2005.06.066","article-title":"The prediction of rapid conversion to Alzheimer\u2019s disease in mild cognitive impairment using regional cerebral blood flow SPECT","volume":"28","author":"Hirao","year":"2005","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-201451_ref9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-201451_ref10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2214\/ajr.149.2.351","article-title":"MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging","volume":"149","author":"Fazekas","year":"1987","journal-title":"AJR Am J Roentgenol"},{"key":"10.3233\/JAD-201451_ref11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-201451_ref12","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/jmri.1139","article-title":"An integrated visualization system for surgical planning and guidance using image fusion and an open MR","volume":"13","author":"Gering","year":"2001","journal-title":"J Magn Reson Imaging"},{"key":"10.3233\/JAD-201451_ref13","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1212\/WNL.62.4.556","article-title":"Diagnostic utility of abbreviated fluency measures in Alzheimer disease and vascular dementia","volume":"62","author":"Canning","year":"2004","journal-title":"Neurology"},{"key":"10.3233\/JAD-201451_ref14","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1017\/S1355617706060590","article-title":"Verbal fluency patterns in amnestic mild cognitive impairment are characteristic of Alzheimer\u2019s type dementia","volume":"12","author":"Murphy","year":"2006","journal-title":"J Int Neuropsychol Soc"},{"issue":"Suppl 4","key":"10.3233\/JAD-201451_ref15","doi-asserted-by":"crossref","first-page":"S393","DOI":"10.3233\/JAD-141473","article-title":"White matter hyperintensities as early and independent predictors of Alzheimer\u2019s disease risk","volume":"42","author":"Mortamais","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-201451_ref16","doi-asserted-by":"crossref","first-page":"e56972","DOI":"10.1371\/journal.pone.0056972","article-title":"Spatial distribution of cerebral white matter lesions predicts progression to mild cognitive impairment and dementia","volume":"8","author":"Mortamais","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JAD-201451_ref17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1212\/01.WNL.0000130530.55104.B5","article-title":"White matter lesions impair frontal lobe function regardless of their location","volume":"63","author":"Tullberg","year":"2004","journal-title":"Neurology"},{"key":"10.3233\/JAD-201451_ref18","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/bmj.322.7300.1447","article-title":"Midlife vascular risk factors and Alzheimer\u2019s disease in later life: Longitudinal, population based study","volume":"322","author":"Kivipelto","year":"2001","journal-title":"BMJ"},{"key":"10.3233\/JAD-201451_ref19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12877-018-0813-4","article-title":"Association between vascular comorbidity and progression of Alzheimer\u2019s disease: A two-year observational study in Norwegian memory clinics","volume":"18","author":"Eldholm","year":"2018","journal-title":"BMC Geriatr"},{"key":"10.3233\/JAD-201451_ref20","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","article-title":"Diabetes mellitus and the risk of dementia: The Rotterdam Study","volume":"53","author":"Ott","year":"1999","journal-title":"Neurology"},{"key":"10.3233\/JAD-201451_ref21","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00127-018-1581-3","article-title":"Mild cognitive impairment and progression to dementia in people with diabetes, prediabetes and metabolic syndrome: A systematic review and meta-analysis","volume":"53","author":"Pal","year":"2018","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"10.3233\/JAD-201451_ref22","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.21009","article-title":"Cognitive impact of subcortical vascular and Alzheimer\u2019s disease pathology","volume":"60","author":"Chui","year":"2006","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-201451_ref23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1600-0404.2007.00984.x","article-title":"Cystatin C expression in ischemic white matter lesions","volume":"118","author":"Umegae","year":"2008","journal-title":"Acta Neurol Scand"},{"key":"10.3233\/JAD-201451_ref24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/jnen\/60.1.94","article-title":"Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients","volume":"60","author":"Levy","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-201451_ref25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neuron.2008.10.001","article-title":"Cystatin C-cathepsin B axis regulates amyloid beta levels and associated neuronal deficits in an animal model of Alzheimer\u2019s disease","volume":"60","author":"Sun","year":"2008","journal-title":"Neuron"},{"key":"10.3233\/JAD-201451_ref26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-019-04977-9","article-title":"Cognitive dysfunction in diabetes: How to implement emerging guidelines","volume":"63","author":"Biessels","year":"2020","journal-title":"Diabetologia"},{"key":"10.3233\/JAD-201451_ref27","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.neurobiolaging.2009.10.009","article-title":"Efficacy of PPAR-\u03b3 agonist pioglitazone in mild Alzheimer disease","volume":"32","author":"Sato","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-201451_ref28","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/ggi.13612","article-title":"Ambulatory glucose profile in diabetes-related dementia","volume":"19","author":"Ogawa","year":"2019","journal-title":"Geriatr Gerontol Int"},{"key":"10.3233\/JAD-201451_ref29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13195-020-00658-7","article-title":"The contribution of vascular risk factors in neurodegenerative disorders: From mild cognitive impairment to Alzheimer\u2019s disease","volume":"12","author":"Cheng","year":"2020","journal-title":"Alzheimers Res Ther"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-201451","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:05:12Z","timestamp":1777370712000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-201451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,23]]},"references-count":29,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-201451","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,23]]}}}